Amgen
AMGN
NASDAQ
IPO1983
about AMGN
Amgen is a biotechnology company that develops innovative medicines to treat serious diseases, utilizing cutting-edge scientific research and technological advancements to improve patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $279.50 | $282.08 | $278.78 | $150.84B | 1.73M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$2.66 | 22.73 | 16.68 | 28.94% | 15.60% | 3.36% |